SCHEMBL2909683

SCHEMBL2909683

C[C@@H](CO)NC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.38
GSK3A P49840 3/20 0.38
ALDH1A1 P00352 4/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.35
CDK1 P06493 2/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
CCNB2 O95067 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNB3 Q8WWL7 1/20 0.34
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
POLB P06746 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
DGAT2 Q96PD7 2/20 0.33
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2909735 1.00 GSK3B (0.38) GSK3BGSK3AALDH1A1SMN1; SMN2SCN10A
SCHEMBL2904789 0.91 GSK3B (0.48) GSK3BGSK3AALDH1A1SMN1; SMN2SCN10A
SCHEMBL12892551 0.91 GSK3B (0.48) GSK3BGSK3AALDH1A1SMN1; SMN2SCN10A
SCHEMBL2910831 0.91 GSK3B (0.48) GSK3BGSK3AALDH1A1SMN1; SMN2SCN10A
SCHEMBL2913460 0.90 GSK3B (0.40) GSK3BGSK3AALDH1A1SMN1; SMN2SCN10A
SCHEMBL2907240 0.90 GSK3B (0.40) GSK3BGSK3AALDH1A1SMN1; SMN2SCN10A
SCHEMBL2911532 0.89 ALDH1A1 (0.41) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2910371 0.89 ALDH1A1 (0.41) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2910067 0.89 GSK3B (0.47) GSK3BGSK3AALDH1A1SMN1; SMN2SCN10A
SCHEMBL2908086 0.89 GSK3B (0.47) GSK3BGSK3AALDH1A1SMN1; SMN2SCN10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed